Cite
HARVARD Citation
Chan, H. et al. (2016). Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet gastroenterology and hepatology. pp. 185-195. [Online].